BioVoice News June 2017 Issue 1 Volume 2 | Page 31

Siraj had previously founded PharmARC, which was acquired by IMS health. In addition to being an active angel investor, he also has extensive experience in the global pharmaceutical industry (BMS), and in healthcare investment banking (UBS Warburg). SIRAJ DHANANI, FOUNDER AND CEO AVR as he is known popularly, A Vijayrajan is a MedTech veteran with 35+ years of experience including stints as Head of Product Development at GE Medical Systems, Chief Executive at Wipro Health Sciences, and VP at Hewlett Packard. Previously, he led the development of India’s first robotic system for tumor ablation at Perfint Healthcare. A VIJAYRAJAN, FOUNDER AND CTO Jagdish is an ENT surgeon, a Stanford-India Biodesign Fellow 2012, and a serial MedTech innovator (18 devices, one licensed to Medtronic) with core expertise in identifying and analysing unmet clinical needs using the Stanford Biodesign process. DR JAGDISH CHATURVEDI, DIRECTOR, CLINICAL INNOVATIONS AND PARTNERSHIPS BIOVOICENEWS.COM 31